Particle.news

Download on the App Store

Brazil Tightens Blood-Pressure Guidance, Classifies 12/8 as Pre-Hypertension

The update refocuses care on early, risk‑based intervention under a stricter sub‑130/80 target through protocols tailored to Brazil's public health system.

Overview

  • The 2025 guideline from the cardiology, nephrology and hypertension societies was unveiled on September 18 at the 80th Brazilian Congress of Cardiology in São Paulo.
  • Hypertension diagnosis remains at readings of at least 140/90 mmHg, while values of 120–139 systolic and/or 80–89 diastolic are now labeled pre‑hypertension and normal is below 120/80.
  • The recommended blood‑pressure goal for patients with hypertension is now under 130/80 mmHg, with drug therapy considered for pre‑hypertensive patients above 130/80 who are high risk after three months of lifestyle measures.
  • The document adopts global cardiovascular risk assessment with the PREVENT score, emphasizes lifestyle change first, and reinforces best‑practice measurement using in‑office checks plus ambulatory or home monitoring (MAPA/MRPA).
  • A new chapter guides care within the SUS, prioritizing medicines available in the public system and multiprofessional follow‑up, aligning Brazil with recent European and U.S. moves toward intermediate risk categories.